IL33 and granular corneal dystrophy type II: The treatment with IL-37 in ACD rats significantly reduces the swelling in their ear, the infiltration of inflammatory cell, IgE levels, the production of IL-33 and inflammatory cytokine, and inhibits MC recruitment (55).